Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Dec 31, 2019
TickeronGET DAILY SIGNALS
China PMI signals expansion in December manufacturing

China PMI signals expansion in December manufacturing

China’s manufacturing activity expanded in December, as indicated by the nation’s official Purchasing Managers’ Index (PMI) whose reading came in slightly higher than expected.

China PMI for December was 50.2. Any reading above 50 suggests an expansion in activity. Economists polled by Reuters expected the official December manufacturing PMI to come in at 50.1.

Production accelerated and demand increased in December, according to the National Bureau of Statistics.

December was the second straight month of expansion for the index.

On December 13, the U.S. and China announced that they had reached a phase one trade deal, that includes (among several aspects) holding off and reduction of  some U.S.tariffs, increased purchases by China of U.S. agricultural goods, and policies related to intellectual property and technology.

Related Ticker: FXI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FXI's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for FXI turned positive on November 02, 2026. Looking at past instances where FXI's MACD turned positive, the stock continued to rise in 52 of 58 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on FXI as a result. In 80 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

FXI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXI advanced for three days, in 206 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

FXI broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FXI entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks to track the investment results of the FTSE China 50 Index composed of large-capitalization Chinese equities that trade on the Hong Kong Stock Exchange. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.

High and low price notable news

The average weekly price growth across all stocks in the iShares China Large-Cap ETF (FXI) ETF was 6%. For the same ETF, the average monthly price growth was 5%, and the average quarterly price growth was -5%. HKD experienced the highest price growth at -16%, while USD experienced the biggest fall at -23%.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Unknown

Category
Greater China Region
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.